As a lab technician, I'm doing these four things — including turning bath time into a fun experiment — to get my young ...

Life-sciences VC funding in Chicago rose 43% to $287.6M in 2024. But that's way off the $8.5B raised in California's Bay Area ...

Becton's life sciences division makes diagnostic products such as those used to detect infectious diseases and cancers. Earlier this week, the Financial Times reported activist investor Starboard ...

In recent transactions involving abrdn Life Sciences Investors (NYSE:HQL), significant sales of common stock were reported by ...

In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on ATAI Life Sciences (ATAI – Research Report), with ...

Becton Dickinson said on Wednesday its board has authorized a plan to separate its life sciences unit as the medical device maker aims to focus on its core business.

Amid the federal funding uncertainty for health and sciences, local life science leaders say this could be a moment for industry partners, investors and others to step up and support the sector.

One of the newest engineering marvels to come out of Kendall Square will be buried up to 105 feet underground where no one ...

Discover the top dividend growth companies in heavily discounted sectors, offering attractive yields for savvy investors.

Bio-Techne beat second-quarter profit and revenue estimates on Wednesday, helped by growth in its protein sciences unit that makes products to develop therapies ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Bio-Techne Corporation (TECH) stock climbs as its Q2 FY25 results exceed Wall Street estimates amid recovery in the biopharma end market. Read more here.